While PET scans have been used to predict Hodgkin lymphoma outcomes, adding Adcetris to frontline therapy improved outcomes for patients, regardless of their results. Adding Adcetris (brentuximab ...

The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...

DEAR MAYO CLINIC: My father just started chemotherapy for lymphoma, and he is scheduled for a positron emission tomography, or PET scan, after his first three treatments. How do doctors decide when to ...

EOT Signatera-positivity was prognostic of significantly inferior event-free survival (EFS) (adj HR: 45.33; p<0.0001) and was the strongest independent predictor of EFS in a multivariate analysis (HR: ...

Circulating tumor DNA (ctDNA) minimal residual disease (MRD) assessment at treatment completion provides superior prognostic accuracy compared with PET in large B-cell lymphoma. The CLARITY assay ...

To evaluate the use of interim positron emission tomography-computed tomography (PET-CT) scans and Deauville 5-point scale (5PS) score reporting for stage III/IV classic Hodgkin lymphoma (cHL) treated ...

Metabolic tumor volume—a biomarker derived from PET imaging—can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index ...

After being treated for diffuse large B-cell lymphoma (DLBCL), a negative readout from a PET scan should be good news for patients. The test tracks radiolabelled sugars as they’re broken down by the ...

Early [¹⁸F]fluorodeoxyglucose (FDG) PET-CT assessment after one cycle of brentuximab vedotin-based chemotherapy in advanced‑stage classical Hodgkin lymphoma allowed selective treatment intensification ...

Neoadjuvant Chemotherapy in Colon Cancer: More Than Just an Optical Illusion In the article that accompanies this editorial, Jemaa et al 12 present a machine learning model for the reading and ...